Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit
abx092223-100l 100 µl
EUR 650

Human IgG antibody Laboratories manufactures the anticancer monoclonal igm reagents distributed by Genprice. The Anticancer Monoclonal Igm reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm monoclonal. Other Anticancer products are available in stock. Specificity: Anticancer Category: Monoclonal Group: Igm

Human Phosphatidylinositol Antibody IgG/IgM (PIAb-IgG/IgM) ELISA Kit
5x96-Strip-Wells
EUR 3420

Human Phosphatidylinositol Antibody IgG/IgM (PIAb-IgG/IgM) ELISA Kit
96-Strip-Wells
EUR 765

Goat anti Human IgG and IgM (H&L)
1 ml Ask for price

Hepatitis A Virus IgG and IgM (HAV IgG + IgM) Rapid Test Kit
100 µl
EUR 650

Hepatitis A Virus IgG and IgM (HAV IgG + IgM) Rapid Test Kit
1 ml
EUR 7200

Hepatitis A Virus IgG and IgM (HAV IgG + IgM) Rapid Test Kit
200 µl
EUR 2100

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit
96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit
96T
EUR 577.2

human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit
48T
EUR 398.4

Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit
48T
EUR 346.8

Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit
48 Tests Ask for price

Human phosphatidylinositol antibody IgG/IgM(PI Ab-IgG/IgM)ELISA Kit
96T
EUR 559.2

Igm information

Anticancer agent 85
HY-151564 Get quote Ask for price
Description: Anticancer agent 85 (compound 6j) is an anticancer agent that shows good cytotoxicity against MCF7 cells. Anticancer agent 85 can be used in breast cancer and other cancer studies[1].

Anticancer agent 86
HY-151565 Get quote Ask for price
Description: Anticancer agent 86 (compound 6i) shows potential activity against breast adenocarcinoma[1].

Anticancer agent 87
HY-151570 Get quote Ask for price
Description: Anticancer agent 87 is a potent anticancer agent. Anticancer agent 87 can be used in the research of breast adenocarcinoma and liver cancer[1].

Anticancer agent 88
HY-151572 Get quote Ask for price
Description: Anticancer agent 88 is a potent anticancer agent. Anticancer agent 88 can be used in the research of breast adenocarcinoma and liver cancer[1].

Anticancer agent 89
HY-151587 Get quote Ask for price
Description: Anticancer agent 89 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity, has high inhibition against the three cell line from ovarian cancer (OVCAR-4), renal cancer (A498), and melanoma (SK-MEL-5)[1].

Anticancer agent 90
HY-151588 Get quote Ask for price
Description: Anticancer agent 90 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor activity. Anticancer agent 90 has high inhibition against the two cell line from ovarian cancer (OVCAR-4), renal cancer (A498)[1].

Anticancer agent 91
HY-151592 Get quote Ask for price
Description: Anticancer agent 91 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. Anticancer agent 91 has high inhibition against the two cell line from CNS cancer (SF-539 and SNB-75)[1].

Anticancer agent 92
HY-151888 Get quote Ask for price
Description: Anticancer agent 92 (Compound 5f) is an anticancer agent that is nontoxic against noncancerous cells[1].

Anticancer agent 93
HY-152084 Get quote Ask for price
Description: Anticancer agent 93 is a 4-Hydroxycoumarin derivative. Anticancer agent 93 can inhibit invasion and migration of lung cancer cells by modulating expression of epithelial-mesenchymal transition (EMT) effectors[1].

Anticancer agent 94
HY-152085 Get quote Ask for price
Description: Anticancer agent 94 is a 4-Hydroxycoumarin derivative. Anticancer agent 94 can inhibit invasion and migration of lung cancer cells by modulating expression of epithelial-mesenchymal transition (EMT) effectors[1].

Anticancer agent 9
HY-78884 10 mg
EUR 346.33
Description: Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1].

Anticancer agent 131
HY-149327 Get quote Ask for price
Description: HCT-116-IN-1, a γ-lactam-fused pyridone derivative, has anticancer activity and displayed high cytotoxicity against HCT116 cells with an IC50 of 5.59 μM[1].

Anticancer agent 132
HY-149343 Get quote Ask for price
Description: Anticancer agent 132 (compound Rh1) is an inducer of apoptosis and autophagy with antitumor and antimetastasis activity. Anticancer agent 132 arrests cell cycle and inhibits cell proliferation[1].

Anticancer agent 133
HY-149344 Get quote Ask for price
Description: Anticancer agent 133 (compound Rh2) is an anti-cancer agent with cytotoxic and antimetastatic activities. Anticancer agent 133 induces cell cycle arrest, apoptosis, and autophagy. Anticancer agent 133 also inhibits cell metastasis via suppression of EGFR expression mediated by FAK-regulated integrin β1[1].

Anticancer agent 136
HY-149367 Get quote Ask for price
Description: Anticancer agent 136 (compound 22), a C17-triazole analogue of Geldanamycin (GDM; HY-15230), has an IC50 of 3.38 μM for HDF and a Kd of 3.86 μM for Hsp90. Anticancer agent 136 is an apoptosis-inducing agent[1].

Anticancer agent 139
HY-149388 Get quote Ask for price
Description: Anticancer agent 139 (Compound 6h) has potent anticancer activity. Anticancer agent 139 displayed a π–cationic interaction with the residue Lys352 of Tublin. Anticancer agent 139 has good anticancer activity against SNB-19, OVCAR-8, and NCI-H40 with PGIs of 86.61, 85.26, and 75.99, respectively. Anticancer agent 139 also has moderate anticancer activity against HOP-62, SNB-75, ACHN, NCI/ADR-RES, 786-O, A549/ATCC, HCT-116, and MDA-MB-231 with PGIs of 67.55, 65.46, 59.09, 59.02, 57.88, 56.88, 56.53, 56.4, and 51.88 respectively[1].

Anticancer agent 157
HY-149523 Get quote Ask for price
Description: Anticancer agent 157 (compound 15) is a NO inhibitor (IC50=0.62 μg/mL) with anti-inflammatory and anticancer activities. Anticancer agent 157 can bind to iNOS (inducible NO synthase) and caspase 8, causing nuclear fragmentation and chromatin condensation, inducing apoptosis. Anticancer agent 157 inhibits HT29 colon cancer cells (IC50=2.45 μg/mL), Hep-G2 liver cancer cells (IC50=3.25 μg/mL), and B16-F10 murine melanoma cells (IC50=3.84 μg/mL)[1].

Anticancer agent 110
HY-149805 Get quote Ask for price
Description: Anticancer agent 110 is an anticancer agent with in vitro anticancer activity and excellent anti-leukemia potency. Anticancer agent 110 is highly cytotoxic to K-562 lineage chronic myelogenous leukemia cells at nanomolar concentrations. Anticancer agent 110 causes DNA damage and leads to apoptosis[1].

Anticancer agent 114
HY-149832 Get quote Ask for price
Description: Anticancer agent 114 is a potent and orally active dipeptide boronic acid ester proteasome inhibitor with an IC50 value of 2.2 nM. Anticancer agent 114 has antiproliferative activity against the RPMI-8226 cells. Anticancer agent 114 can be used in research of multiple myeloma[1].

Anticancer agent 126
HY-149873 Get quote Ask for price
Description: Anticancer agent 126 (compound 12) is a WDR5 inhibitor with anticancer effects. Anticancer agent 126 disrupts WDR5-MYC interaction in cells and reduce MYC target gene expression[1].

Anticancer agent 130
HY-149890 Get quote Ask for price
Description: Anticancer agent 130 (compound 8d) is an anticancer agent that can significantly induce apoptosis in A549 cells[1].

Anticancer agent 98
HY-149920 Get quote Ask for price
Description: Anticancer agent 98 (compound 12k) is a microtubule/tubulin-polymerization inhibitor (Kd=16.9 μM). Anticancer agent 98 exerts antiproliferative potency against tumor cells, exhibits anti-angiogenesis effect in vitro. Anticancer agent 98 exhibits good human and mouse liver microsomes stability with both t1/2>300 min[1].

Anticancer agent 105
HY-149949 Get quote Ask for price
Description: Anticancer agent 105 is a compound based on thienopyrimidine scaffold, with with good safety and anticancer properties. Anticancer agent 105 shows selective toxicity towards melanoma cancer, and induces apoptosis. And Anticancer agent 105 significantly inhibits the metastatic nodules, even in pulmonary metastatic melanoma mouse model[1].

Anticancer agent 106
HY-149950 Get quote Ask for price
Description: Anticancer agent 106 (compound 10ic) is an anticancer agent that induces apoptosis in B16-F10 melanoma cells. Anticancer agent 106 also potently inhibits metastatic nodules in a mouse model of lung metastatic melanoma. Anticancer agent 106 can be used in the study of cancer, especially lung metastatic melanoma[1].

Anticancer agent 107
HY-149951 Get quote Ask for price
Description: Anticancer agent 107(Compd 11jc) has significant antitumor activity and can be used as an anticancer agent in the study of pulmonary metastatic melanoma[1].

Anticancer agent 111
HY-149977 Get quote Ask for price
Description: Anticancer agent 111 (compound 11) is a potent cytochrome P450 inhibitor with an IC50 value of 3 μM for CYP3A4. Anticancer agent 111 has anticancer activity. Anticancer agent 111 can be used in research of cancer[1].

Anticancer agent 120
HY-149997 Get quote Ask for price
Description: Anticancer agent 120 (compound 21) is an N-acylated ciprofloxacin derivative, which has certain antibacterial activity and induces ROS to promote cancer cell apoptosis[1].

Anticancer agent 76
HY-150571 Get quote Ask for price
Description: Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferation of human NSCLC cells, induces cell cycle arrest, causes ROS generation and induces cell apoptosis[1].